Spineway Cash Flow Conversion Efficiency
Spineway cash flow conversion efficiency. Based on the latest financial reports, Spineway (ALSPW) has a cash flow conversion efficiency ratio of -0.005x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-114.00K ≈ $-133.28K USD) by net assets (€23.06 Million ≈ $26.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Spineway (2011–2025)
Cash flow conversion efficiency of Spineway from 2011 to 2025. This chart illustrates how Spineway's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ALSPW live share price for real-time trading data and today's change.
Spineway Cash Flow Conversion Ratio Explained
Spineway cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Spineway Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Spineway ranked by their cash flow conversion efficiency. Also see ALSPW market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mesa Royalty Trust
NYSE:MTR
|
0.162x |
|
Monsenso AS
CO:MONSO
|
-0.251x |
|
BuilderSmart Public Company Limited
BK:BSM
|
0.083x |
|
Techfast Holdings Bhd
KLSE:0084
|
0.129x |
|
FW Thorpe PLC
LSE:TFW
|
0.088x |
|
E-Home Household Service Holdings Ltd
NASDAQ:EJH
|
0.004x |
|
DFS Furniture PLC
LSE:DFS
|
0.354x |
|
Indo Pureco Pratama Tbk PT
JK:IPPE
|
0.000x |
Annual Cash Flow Conversion Efficiency for Spineway (2011–2025)
The table below shows the annual cash flow conversion efficiency of Spineway from 2011 to 2025. Review ALSPW FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €23.06 Million ≈ $26.96 Million |
€424.00K ≈ $495.70K |
0.018x | +113.61% |
| 2024-12-31 | €24.24 Million ≈ $28.34 Million |
€-3.27 Million ≈ $-3.83 Million |
-0.135x | +55.85% |
| 2023-12-31 | €19.05 Million ≈ $22.28 Million |
€-5.83 Million ≈ $-6.81 Million |
-0.306x | -315.53% |
| 2022-12-31 | €22.01 Million ≈ $25.73 Million |
€-1.62 Million ≈ $-1.89 Million |
-0.074x | +14.38% |
| 2021-12-31 | €20.88 Million ≈ $24.41 Million |
€-1.79 Million ≈ $-2.10 Million |
-0.086x | -111.09% |
| 2020-12-31 | €10.02 Million ≈ $11.71 Million |
€-408.00K ≈ $-476.99K |
-0.041x | +77.22% |
| 2019-12-31 | €6.49 Million ≈ $7.59 Million |
€-1.16 Million ≈ $-1.36 Million |
-0.179x | +95.04% |
| 2018-12-31 | €945.00K ≈ $1.10 Million |
€-3.41 Million ≈ $-3.99 Million |
-3.608x | -593.91% |
| 2017-12-31 | €1.77 Million ≈ $2.07 Million |
€-922.00K ≈ $-1.08 Million |
-0.520x | -241.43% |
| 2016-12-31 | €1.30 Million ≈ $1.52 Million |
€-198.00K ≈ $-231.48K |
-0.152x | -364.80% |
| 2015-12-31 | €3.02 Million ≈ $3.53 Million |
€-99.00K ≈ $-115.74K |
-0.033x | +91.21% |
| 2014-12-31 | €4.62 Million ≈ $5.41 Million |
€-1.72 Million ≈ $-2.01 Million |
-0.373x | -68.98% |
| 2013-12-31 | €5.12 Million ≈ $5.99 Million |
€-1.13 Million ≈ $-1.32 Million |
-0.221x | -167.96% |
| 2012-12-31 | €1.16 Million ≈ $1.36 Million |
€378.00K ≈ $441.92K |
0.324x | +172.35% |
| 2011-12-31 | €844.99K ≈ $987.88K |
€-379.00K ≈ $-443.09K |
-0.449x | -- |
About Spineway
Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The comp… Read more